Both in vitro and in vivo studies in ovarian cancer observed that claudin-4 promotes the angiogenesis by inducing the production of angiogenic factors such as IL-8 (Li et al., 2009), suggesting the pro-angiogenic role of claudin-4 in ovarian cancer. Here, CXCL8 is linked to ovarian carcinoma.